We employ cookies for advertising, analytics, and to improve your experience using our website. By continuing to use our site, you agree to our use of cookies. For more information, please see our Privacy Policy.
Akorn Issues Voluntary Nationwide Recall of Various Human and Animal Drug Products Within Expiry Due to Company Shutdown
***URGENT DRUG RECALL NOTICE***
FDA PUBLISH DATE: April 26, 2023
SUPPLIER: Akorn Operating Company LLC
PRODUCT TYPE: Drugs (See table below for listing of affected NDCs).
Description:
The Akorn Trustee is voluntarily recalling all lots of the affected items due to discontinuation of the Quality activities of these marketed products as a result of Akorn filing Chapter 7 bankruptcy on February 23, 2023. This recall is to the Consumer level. Akorn has not received any reports of adverse events related to this recall.
The discontinuation of the Quality program means the company will not be able to support or guarantee that the products will meet all intended specifications through the labeled shelf life of the product. Further distribution or use of any remaining product on the market should cease immediately. Akorn has not received any reports of adverse events related to this recall.
Retailer/Customer Information:
Hilco Vison Customer, please examine your inventory for the affected products completely and stop dispensing immediately. If you have the affected products, Akorn is requesting destruction of any recalled products. Product should be destroyed in accordance with Federal, State, and Local laws and regulations.
Only products listed below are affected by the recall. Products not included in the press are continuing to be monitored under a Quality Program and will remain on the market.